Can elevated cortisol and HPA-axis activation worsen premenstrual anxiety and sleep disruption?

Premenstrual mood and sleep disturbances are heavily modulated by the dynamic interplay between stress pathways and ovarian hormones, rather than simple hormonal imbalances.

Cellular and endocrine crosstalk

• HPG axis suppression: Elevated cortisol and HPA-axis activation suppress the hypothalamic-pituitary-gonadal (HPG) axis by inhibiting GnRH release, which subsequently reduces LH and FSH secretion and alters downstream ovarian steroidogenesis.
• Receptor-level interference: At the cellular level, activated glucocorticoid receptors (GR) physically associate with estrogen receptors (ER) and progesterone receptors (PR). This genomic crosstalk disrupts cofactor recruitment, blocks PR-dependent gene regulation, and interferes with ER transcription at key promoters, such as the 5-HT2B receptor promoter.
• Competitive binding: Due to overlapping ligand binding specificities, cortisol directly competes with progesterone for GR binding, turning progesterone's supportive functions into functional antagonism when stress levels are elevated.

Mechanisms of anxiety and sleep disruption

• Neurosteroid sensitivity: Premenstrual anxiety is driven by abnormal central nervous system sensitivity to normal luteal-phase fluctuations of progesterone and its metabolite, allopregnanolone. In sensitive individuals, impaired GABA-A receptor response to allopregnanolone disrupts inhibitory feedback, causing HPA-axis dysregulation, heightened physiological arousal, and flattened diurnal cortisol slopes.
• Circadian misalignment: This neuroendocrine disruption misaligns melatonin and cortisol rhythms during the late luteal phase. The resulting circadian desynchrony directly increases nighttime arousal, leading to subjective premenstrual insomnia, fragmented sleep, and non-restorative rest.

Bottom line

• Premenstrual anxiety and sleep disruption are driven by stress-induced HPA-axis activation that physically interferes with ovarian hormone receptors and impairs GABAergic sensitivity to normal luteal-phase progesterone and allopregnanolone fluctuations.